Evidence map›Paper›PMID 29408935›Full record

ArticlePloS one2018

Depression and smoking characteristics among HIV-positive smokers in Russia: A cross-sectional study.

Karen E Lasser, Karsten Lunze, Debbie M Cheng, Elena Blokhina, Alexander Y Walley, Hilary A Tindle, Emily Quinn, Natalia Gnatienko, Evgeny Krupitsky, Jeffrey H Samet

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Karen E LasserDepartment of Medicine, Section of General Internal Medicine, Boston University Schools of Medicine and Public Health/Boston Medical Center, Boston, Massachusetts, United States of America.
Karsten LunzeDepartment of Medicine, Section of General Internal Medicine, Clinical Addiction Research and Education Unit, Boston University School of Medicine/Boston Medical Center, Boston, Massachusetts, United States of America.
Debbie M ChengDepartment of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, United States of America.
Elena BlokhinaFirst St. Petersburg Pavlov State Medical University, St. Petersburg, Russian Federation.
Alexander Y WalleyDepartment of Medicine, Section of General Internal Medicine, Clinical Addiction Research and Education Unit, Boston University School of Medicine/Boston Medical Center, Boston, Massachusetts, United States of America.
Hilary A TindleThe Vanderbilt Center for Tobacco, Addiction, and Lifestyle, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Emily QuinnData Coordinating Center, Boston University School of Public Health, Boston, Massachusetts, United States of America.
Natalia GnatienkoDepartment of Medicine, Section of General Internal Medicine, Clinical Addiction and Research Education Unit, Boston Medical Center, Boston, Massachusetts, United States of America.
Evgeny KrupitskyFirst St. Petersburg Pavlov State Medical University, St. Petersburg, Russian Federation.
Jeffrey H SametDepartment of Medicine, Section of General Internal Medicine, Clinical Addiction Research and Education Unit, Boston University School of Medicine/Boston Medical Center, Boston, Massachusetts, United States of America.
Boston University · USBoston Medical Center · USFirst Pavlov State Medical University of St. Petersburg · RUVanderbilt University · US

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH, DEBBIE M. CHENG · 1998 to 2026
$51.7M
URBAN ARCH 4/5 Russia Cohort-Targeting HIV-comorbidities with Pharmacotherapy to Reduce Alcohol and Tobacco Use in HIV-infected RussiansU01AA020780 · NIAAA · BOSTON MEDICAL CENTER · PI FREIBERG, MATTHEW S, SAMET, JEFFREY H. · 2011 to 2021
$4.4M
URBAN ARCH (2/5) Biostatistics and Data Management Core (BDM)U24AA020779 · NIAAA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CHENG, DEBBIE M. · 2011 to 2020
$3.6M
URBAN ARCH (1/5) Administrative Coordinating Core (Admin Core)U24AA020778 · NIAAA · BOSTON MEDICAL CENTER · PI SAMET, JEFFREY H. · 2011 to 2020
$3.5M
Linking Russian Narcology & HIV Care to Enhance Treatment, Retention, & OutcomesR01DA032082 · NIDA · BOSTON MEDICAL CENTER · PI SAMET, JEFFREY H. · 2011 to 2015
$3.4M
Zinc for HIV Disease among Alcohol Users -An RCT in the Russia ARCH CohortU01AA021989 · NIAAA · BOSTON MEDICAL CENTER · PI FREIBERG, MATTHEW S, SAMET, JEFFREY H. · 2012 to 2016
$3.3M
NIAAA NIH HHS U01 AA020780NIAAA NIH HHS U01 AA021989NIAAA NIH HHS U24 AA020778NIAAA NIH HHS U24 AA020779NIAID NIH HHS P30 AI042853NIDA NIH HHS R01 DA032082NIH HHS R01DA032082NIH HHS U01AA020780NIH HHS U01AA021989NIH HHS U24AA020778NIH HHS U24AA020779
6 · The paper itself

Abstract

introductionGlobally, persons with HIV infection, depression and substance use disorders have a higher smoking prevalence and smoke more heavily than other populations. These associations have not been explored among Russian smokers with HIV infection and substance use disorders. The purpose of this study was to examine the relationship between the presence of depressive symptoms and smoking outcomes in an HIV-positive cohort of Russian smokers with a history of substance use disorders (alcohol and/or drug use disorders).

methodsWe performed a cross-sectional secondary data analysis of a cohort of HIV-positive regular smokers with a history of substance use disorders recruited in St. Petersburg, Russia in 2012-2015. The primary outcome was heavy smoking, defined as smoking > 20 cigarettes per day. Nicotine dependence (moderate-very high) was a secondary outcome. The main independent variable was a high level of depressive symptoms in the past 7 days (defined as CES-D > = 24). We used multivariable logistic regression to examine associations between depressive symptoms and the outcomes, controlling for age, sex, education, income, running out of money for housing/food, injection drug use, and alcohol use measured by the AUDIT.

resultsAmong 309 regular smokers, 79 participants (25.6%) had high levels of depressive symptoms, and 65 participants (21.0%) were heavy smokers. High levels of depressive symptoms were not significantly associated with heavy smoking (adjusted odds ratio [aOR] 1.50, 95% CI 0.78-2.89) or with moderate-very high levels of nicotine dependence (aOR 1.35, 95% CI 0.75-2.41).

conclusionsThis study did not detect an association between depressive symptoms and smoking outcomes among HIV-positive regular smokers in Russia.

Indexed as

SmokingAdultCross-Sectional StudiesDepressionFemaleHIV InfectionsHumansMaleRussia

Identifiers

PMID29408935
PMCPMC5800551
OpenAlexW2792470216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.